The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells

Journal of Experimental Medicine

Volumn 211, Issue 11, 2014, Pages 2199-2212

  Grötsch, Bettina ^b   Brachs, Sebastian ^a   Lang, Christiane ^a   Luther, Julia ^b,c   Derer, Anja ^b   Schlötzer Schrehardt, Ursula ^b   Bozec, Aline ^b   Fillatreau, Simon ^d   Berberich, Ingolf ^e   Hobeika, Elias ^f   Reth, Michael ^f   Wagner, Erwin F ^g   Schett, Georg ^b   Mielenz, Dirk ^a   David, Jean Pierre ^b,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

^g Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ERROR; ANIMAL; APOPTOSIS; B LYMPHOCYTE; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMORAL IMMUNITY; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PLASMA CELL; PROMOTER REGION; TRANSGENIC MOUSE; ULTRASTRUCTURE;

PRDM1 PROTEIN, MOUSE; PROTEIN BINDING; PROTEIN C FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FRA 1;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; IMMUNITY, HUMORAL; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; PLASMA CELLS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; TRANSCRIPTION FACTORS;

EID: 84908249596     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20130795     Document Type: Article

References (50)

1. Arguni, E., M. Arima, N. Tsuruoka, A. Sakamoto, M. Hatano, and T. Tokuhisa. 2006. JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells. Int. Immunol. 18:1079- 1089. http://dx.doi.org/10.1093/intimm/dxl041
2. De Silva, N.S., G. Simonetti, N. Heise, and U. Klein. 2012. The diverse roles of IRF4 in late germinal center B-cell differentiation. Immunol. Rev. 247:73-92. http://dx.doi.org/10.1111/j.1600-065X.2012.01113.x
3. Delogu, A., A. Schebesta, Q. Sun, K. Aschenbrenner, T. Perlot, and M. Busslinger. 2006. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity. 24:269-281. http://dx .doi.org/10.1016/j.immuni.2006.01.012
4. Eferl, R., A. Hoebertz, A.F. Schilling, M. Rath, F. Karreth, L. Kenner, M. Amling, and E.F. Wagner. 2004. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J. 23:2789-2799. http://dx.doi.org/10.1038/ sj.emboj.7600282
5. Fleischmann, A., F. Hafezi, C. Elliott, C.E. Remé, U. Rüther, and E.F. Wagner. 2000. Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev. 14:2695-2700. http://dx.doi.org/10.1101/gad.187900
6. Foletta, V.C., D.H. Segal, and D.R. Cohen. 1998. Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukoc. Biol. 63:139-152.
7. Gass, P., A. Fleischmann, O. Hvalby, V. Jensen, C. Zacher, T. Strekalova, A. Kvello, E.F. Wagner, and R. Sprengel. 2004. Mice with a fra-1 knock-in into the c-fos locus show impaired spatial but regular contextual learning and normal LTP. Brain Res. Mol. Brain Res. 130:16-22. http://dx.doi.org/10 .1016/j.molbrainres.2004.07.004
8. Hess, J., P. Angel, and M. Schorpp-Kistner. 2004. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117:5965-5973. http://dx.doi.org/10 .1242/jcs.01589
9. Hobeika, E., S. Thiemann, B. Storch, H. Jumaa, P.J. Nielsen, R. Pelanda, and M. Reth. 2006. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA. 103:13789-13794. http://dx.doi.org/10 .1073/pnas.0605944103
10. Huo, L., and T.L. Rothstein. 1995. Receptor-specific induction of individual AP-1 components in B lymphocytes. J. Immunol. 154:3300-3309.
11. Huo, L., and T.L. Rothstein. 1996. Isolation and characterization of murine fra-1: induction mediated by CD40 and surface Ig is protein kinase C dependent. J. Immunol. 157:3812-3818.
12. Jochum, W., J.P. David, C. Elliott, A. Wutz, H. Plenk Jr., K. Matsuo, and E.F. Wagner. 2000. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat. Med. 6:980-984. http:// dx.doi.org/10.1038/79676
13. Kallies, A., J. Hasbold, D.M. Tarlinton, W. Dietrich, L.M. Corcoran, P.D. Hodgkin, and S.L. Nutt. 2004. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J. Exp. Med. 200:967-977. http:// dx.doi.org/10.1084/jem.20040973
14. Kallies, A., J. Hasbold, K. Fairfax, C. Pridans, D. Emslie, B.S. McKenzie, A.M. Lew, L.M. Corcoran, P.D. Hodgkin, D.M. Tarlinton, and S.L. Nutt. 2007. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1. Immunity. 26:555-566. http://dx.doi.org/10.1016/j.immuni .2007.04.007
15. Klein, U., and R. Dalla-Favera. 2008. Germinal centres: role in B-cell physiology and malignancy. Nat. Rev. Immunol. 8:22-33. http://dx.doi.org/10 .1038/nri2217
16. Knödel, M., A.W. Kuss, D. Lindemann, I. Berberich, and A. Schimpl. 1999. Reversal of Blimp-1-mediated apoptosis by A1, a member of the Bcl-2 family. Eur. J. Immunol. 29:2988-2998. http://dx.doi.org/10.1002/(SICI) 1521-4141(199909)29:09<2988::AID-IMMU2988>3.0.CO;2-T
17. Knödel, M., A.W. Kuss, I. Berberich, and A. Schimpl. 2001. Blimp-1 overexpression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching. Eur. J. Immunol. 31:1972- 1980. http://dx.doi.org/10.1002/1521-4141(200107)31:7<1972::AIDIMMU1972> 3.0.CO;2-T
18. Körholz, D., S. Gerdau, J. Enczmann, N. Zessack, and S. Burdach. 1992. Interleukin 6-induced differentiation of a human B cell line into IgMsecreting plasma cells is mediated by c-fos. Eur. J. Immunol. 22:607-610. http://dx.doi.org/10.1002/eji.1830220248
19. Krum, S.A., J. Chang, G. Miranda-Carboni, and C.Y. Wang. 2010. Novel functions for NF?B: inhibition of bone formation. Nat Rev Rheumatol. 6:607-611. http://dx.doi.org/10.1038/nrrheum.2010.133
20. Kwon, H., D. Thierry-Mieg, J. Thierry-Mieg, H.P. Kim, J. Oh, C. Tunyaplin, S. Carotta, C.E. Donovan, M.L. Goldman, P. Tailor, et al. 2009. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity. 31:941-952. http://dx.doi.org/10.1016/j.immuni.2009.10.008
21. Lin, K.I., C. Angelin-Duclos, T.C. Kuo, and K. Calame. 2002. Blimp-1- dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol. Cell. Biol. 22:4771- 4780. http://dx.doi.org/10.1128/MCB.22.13.4771-4780.2002
22. Loder, F., B. Mutschler, R.J. Ray, C.J. Paige, P. Sideras, R. Torres, M.C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptorderived signals. J. Exp. Med. 190:75-89. http://dx.doi.org/10.1084/ jem.190.1.75
23. Lopes-Carvalho, T., and J.F. Kearney. 2004. Development and selection of marginal zone B cells. Immunol. Rev. 197:192-205. http://dx.doi.org/10.1111/ j.0105-2896.2004.0112.x
24. Luther, J., F. Driessler, M. Megges, A. Hess, B. Herbort, V. Mandic, M.M. Zaiss, A. Reichardt, C. Zech, J.P. Tuckermann, et al. 2011. Elevated Fra-1 expression causes severe lipodystrophy. J. Cell Sci. 124:1465-1476. http:// dx.doi.org/10.1242/jcs.079855
25. Manz, R.A., A.E. Hauser, F. Hiepe, and A. Radbruch. 2005. Maintenance of serum antibody levels. Annu. Rev. Immunol. 23:367-386. http://dx.doi.org/10 .1146/annurev.immunol.23.021704.115723
26. Martin, F., A.M. Oliver, and J.F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 14:617-629. http://dx.doi.org/10.1016/S1074-7613(01) 00129-7
27. Matsuo, K., J.M. Owens, M. Tonko, C. Elliott, T.J. Chambers, and E.F. Wagner. 2000. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24:184-187. http://dx.doi.org/10 .1038/72855
28. Meister, S., B. Frey, V.R. Lang, U.S. Gaipl, G. Schett, U. Schlötzer-Schrehardt, and R.E. Voll. 2010. Calcium channel blocker verapamil enhances endoplasmic reticulum stress and cell death induced by proteasome inhibition in myeloma cells. Neoplasia. 12:550-561.
29. Moser, K., K. Tokoyoda, A. Radbruch, I. MacLennan, and R.A. Manz. 2006. Stromal niches, plasma cell differentiation and survival. Curr. Opin. Immunol. 18:265-270. http://dx.doi.org/10.1016/j.coi.2006.03.004
30. Nera, K.P., P. Kohonen, E. Narvi, A. Peippo, L. Mustonen, P. Terho, K. Koskela, J.M. Buerstedde, and O. Lassila. 2006. Loss of Pax5 promotes plasma cell differentiation. Immunity. 24:283-293. http://dx.doi.org/10 .1016/j.immuni.2006.02.003
31. Nutt, S.L., B. Heavey, A.G. Rolink, and M. Busslinger. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 401:556-562. http://dx.doi.org/10.1038/44076
32. Nutt, S.L., N. Taubenheim, J. Hasbold, L.M. Corcoran, and P.D. Hodgkin. 2011. The genetic network controlling plasma cell differentiation. Semin. Immunol. 23:341-349. http://dx.doi.org/10.1016/j.smim.2011 .08.010
33. Ochiai, K., Y. Katoh, T. Ikura, Y. Hoshikawa, T. Noda, H. Karasuyama, S. Tashiro, A. Muto, and K. Igarashi. 2006. Plasmacytic transcription factor Blimp-1 is repressed by Bach2 in B cells. J. Biol. Chem. 281:38226-38234. http:// dx.doi.org/10.1074/jbc.M607592200
34. Ohkubo, Y., M. Arima, E. Arguni, S. Okada, K. Yamashita, S. Asari, S. Obata, A. Sakamoto, M. Hatano, J. O-Wang, et al. 2005. A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation. J. Immunol. 174:7703-7710. http://dx.doi.org/10.4049/jimmunol.174.12.7703
35. Peperzak, V., I.B. Vikstrom, and D.M. Tarlinton. 2012. Through a glass less darkly: apoptosis and the germinal center response to antigen. Immunol. Rev. 247:93-106. http://dx.doi.org/10.1111/j.1600-065X.2012 .01123.x
36. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature. 381:751-758. http://dx.doi.org/10.1038/381751a0
37. Reimold, A.M., P.D. Ponath, Y.S. Li, R.R. Hardy, C.S. David, J.L. Strominger, and L.H. Glimcher. 1996. Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J. Exp. Med. 183:393-401. http://dx.doi.org/10.1084/ jem.183.2.393
38. Rinkenberger, J.L., J.J. Wallin, K.W. Johnson, and M.E. Koshland. 1996. An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity. 5:377-386. http://dx.doi.org/ 10.1016/S1074-7613(00)80263-0
39. Sciammas, R., A.L. Shaffer, J.H. Schatz, H. Zhao, L.M. Staudt, and H. Singh. 2006. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity. 25:225-236. http://dx.doi.org/10.1016/j.immuni.2006.07.009
40. Shaffer, A.L., K.I. Lin, T.C. Kuo, X. Yu, E.M. Hurt, A. Rosenwald, J.M. Giltnane, L. Yang, H. Zhao, K. Calame, and L.M. Staudt. 2002. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity. 17:51-62. http://dx.doi.org/10.1016/ S1074-7613(02)00335-7
41. Shapiro-Shelef, M., K.I. Lin, D. Savitsky, J. Liao, and K. Calame. 2005. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J. Exp. Med. 202:1471-1476. http://dx.doi.org/10.1084/ jem.20051611
42. Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:E131-E136. http://dx.doi.org/10.1038/ncb0502-e131
43. Strasser, A., S. Whittingham, D.L. Vaux, M.L. Bath, J.M. Adams, S. Cory, and A.W. Harris. 1991. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA. 88:8661-8665. http://dx.doi.org/10.1073/pnas.88 .19.8661
44. Sutherland, J.A., A. Cook, A.J. Bannister, and T. Kouzarides. 1992. Conserved motifs in Fos and Jun define a new class of activation domain. Genes Dev. 6:1810-1819. http://dx.doi.org/10.1101/gad.6.9.1810
45. Tunyaplin, C., A.L. Shaffer, C.D. Angelin-Duclos, X. Yu, L.M. Staudt, and K.L. Calame. 2004. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J. Immunol. 173:1158-1165. http://dx.doi.org/10.4049/ jimmunol.173.2.1158
46. Vasanwala, F.H., S. Kusam, L.M. Toney, and A.L. Dent. 2002. Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J. Immunol. 169:1922-1929. http://dx.doi.org/10.4049/jimmunol.169.4.1922
47. Victora, G.D., and M.C. Nussenzweig. 2012. Germinal centers. Annu. Rev. Immunol. 30:429-457. http://dx.doi.org/10.1146/annurev-immunol-020711-075032
48. Wagner, E.F., and R. Eferl. 2005. Fos/AP-1 proteins in bone and the immune system. Immunol. Rev. 208:126-140. http://dx.doi.org/10.1111/j.0105- 2896.2005.00332.x
49. Wenzel, A., H.P. Iseli, A. Fleischmann, F. Hafezi, C. Grimm, E.F. Wagner, and C.E. Remé. 2002. Fra-1 substitutes for c-Fos in AP-1-mediated signal transduction in retinal apoptosis. J. Neurochem. 80:1089-1094. http:// dx.doi.org/10.1046/j.0022-3042.2002.00807.x
50. Yu, Z., S. Sato, P.C. Trackman, K.H. Kirsch, and G.E. Sonenshein. 2012. Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide. PLoS ONE. 7:e33287. http://dx.doi.org/10.1371/journal.pone .0033287